Pharmacotherapy of bronchopulmonary dysplasia: A personalized approach

The lecture, based on relevant international and domestic consensus documents, research results, and authors' experience, provides relevant information on personalized pharmacotherapy of bronchopulmonary dysplasia (BPD), including the use of drugs of such groups as systemic and inhaled glucocorticosteroids, methylxanthines, inhaled bronchodilators, diuretics. It provides modern definition of the disease and its diagnostic criteria, goals of therapy. Indications, treatment regimens, dosages, contraindications and side effects of drugs of these groups in children with BPD of different ages at different stages of treatment and observation are described. © 2020, Pediatria Ltd.. All rights reserved.

Авторы
Ovsyannikov D.Y. 1 , Boitsova E.V.2 , Pavlinova E.B.3 , Zhestkova M.A. 1 , Semyatov S.M. 1
Номер выпуска
2
Язык
Русский
Страницы
216-222
Статус
Опубликовано
Том
99
Год
2020
Организации
  • 1 Peoples’ Friendship University of Russia, Moscow, Russian Federation
  • 2 St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation
  • 3 Omsk State Medical University, Omsk, Russian Federation
Ключевые слова
Bronchopulmonary dysplasia; Medicines; Personalized approach; Prevention; Therapy
Дата создания
02.11.2020
Дата изменения
02.11.2020
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/64935/